VERA files Form 144 for 74,000-share option exercise

VERA notice reports an intended resale of 74,000 shares via an exercise of stock options on 06/23/2026.

Rhea-AI Filing Summary

VERA notice reports an intended resale of 74,000 shares via an exercise of stock options on 06/23/2026. The filing also discloses prior 10b5-1 sales by Marshall Fordyce of 18,500 shares on 05/12/2026 and 22,951 shares on 04/14/2026.

Insights

Securities Compliance Counsel

Regulation 144 notice of planned resale tied to option exercise and prior 10b5-1 sales.

The filing lists an issuer-directed exercise of stock options that results in 74,000 shares available for resale on 06/23/2026. It separately records two completed 10b5-1 plan sales of 18,500 and 22,951 shares.

Cash treatment for the exercise is shown as Cash; the filing does not state who will receive proceeds beyond the issuer line. Subsequent disclosures or settlement reports will show actual resale timing and counterparties.

Key Figures

Resale via option exercise: 74,000 shares 10b5-1 sale (May): 18,500 shares 10b5-1 sale (Apr): 22,951 shares +2 more

5 metrics

Resale via option exercise 74,000 shares Exercise of Stock Options on 06/23/2026

10b5-1 sale (May) 18,500 shares 10b5-1 sale on 05/12/2026

10b5-1 sale (Apr) 22,951 shares 10b5-1 sale on 04/14/2026

Proceeds reported (May sale) $679,747.35 Proceeds from 18,500-share sale on 05/12/2026

Proceeds reported (Apr sale) $1,011,050.49 Proceeds from 22,951-share sale on 04/14/2026

Key Terms

Form 144, 10b5-1, Exercise of Stock Options

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for MARSHALL FORDYCE 2000 Sierra Point Parkway"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Securities To Be Sold | Exercise of Stock Options | 06/23/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does VERA's Form 144 report?

It reports an intended resale of 74,000 shares from an exercise of stock options dated 06/23/2026. It also lists prior 10b5-1 sales by Marshall Fordyce in April and May 2026.

Who conducted recent 10b5-1 sales disclosed in the filing?

The filing shows Marshall Fordyce executed 10b5-1 sales of 22,951 shares on 04/14/2026 and 18,500 shares on 05/12/2026, with reported proceeds included in the notice.

Does the Form 144 state how proceeds are handled?

The notice indicates the exercise method is listed as Cash. It does not provide additional details about proceeds recipients or use beyond the issuer-related exercise entry.

When is the 74,000-share resale scheduled under the filing?

The filing associates the 74,000 shares with an exercise of stock options dated 06/23/2026. The document ties that effective date to the exercise action shown.

Are the prior 10b5-1 sales part of the 74,000 shares?

The filing lists prior 10b5-1 sales separately (April and May 2026). It does not state that those completed sales are included in the 74,000-share exercise amount.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2026 - 04:29 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001859453
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vera Therapeutics, Inc.
SEC File Number	001-40407
Address of Issuer	2000 Sierra Point Parkway, Suite 1200 Brisbane CALIFORNIA 94005
Phone	6507700077
Name of Person for Whose Account the Securities are To Be Sold	MARSHALL FORDYCE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	74000	2843820.00	71782904	06/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/23/2026	Exercise of Stock Options	Issuer			74000	06/23/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MARSHALL FORDYCE 2000 Sierra Point Parkway, Suite 1200 Brisbane CA 94005	Common	05/12/2026	18500	679747.35
10b5-1 Sales for MARSHALL FORDYCE 2000 Sierra Point Parkway, Suite 1200 Brisbane CA 94005	Common	04/14/2026	22951	1011050.49

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	06/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	01/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Marshall Fordyce
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)